Raymond James: 'The topline numbers presented by Black Diamond today indicate that the company has a viable asset in our view'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. ADYEN:NA
8. ADYYF
9. WDAY
10. DVLT

Go back to Raymond James: 'The topline numbers presented by Black Diamond today indicate that the company has a viable asset in our view'

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

May 22, 2026 8:00 AM EDT

CAMBRIDGE, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company... More

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

May 21, 2026 5:13 PM EDT

Preliminary mPFS of 15.2 months; mDOR not reachedRobust CNS activity, with 86% CNS ORR; no patients developed de novo brain metastasesORR 60% in patients with a broad spectrum of EGFR-NCMs, including PACCDose dependent and manageable AE profile, no new safety signals observedWebcast on Thursday, May 21, 2026 at 5:30 pm EDT

CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced positive... More